Host tissues and immune cells

Host tissues and immune cells is a broad, non-specific term referring to the collective biological components of an organism, including somatic cells and the various lineages of the immune system such as leukocytes and lymphocytes [1]. In a pharmacological context, this term is often used to describe the environment of drug action or the systemic interplay involved in conditions such as Graft-versus-host disease (GVHD), where donor immune cells recognize the recipient's host tissues as foreign [2]. Because it encompasses the entire physiological landscape of the host, it does not represent a single molecular target like a receptor or enzyme [3]. Therapeutic strategies targeting this system actually focus on specific molecular mediators within it, such as cytokines (e.g., TNF-alpha) or cell surface markers (e.g., CD20) [4]. Consequently, while critical for understanding systemic disease and drug distribution, the term is too broad for precise molecular classification or targeted drug design [5]. For example, immunosuppressive drugs like cyclosporine act on immune cells to prevent them from attacking host tissues in transplant recipients [6]. Effective therapeutic intervention usually requires identifying specific molecular drivers within these tissues or cells to minimize off-target effects [7].

Other names

Host cellsImmune systemSomatic cells and leukocytes

Modulation of immune cell activity and protection of host tissue integrity through the inhibition of inflammatory mediators and signaling pathways.